Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Pathways in cancer 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬 💬
2 Pathways in cancer 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬 💬
3 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 💬
4 Pathways in cancer 💬
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬 💬
5 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRB 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
6 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRB 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
7 Pathways in cancer 💬
1件: AGTR1 💬 Angiotensin II 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬 💬
8 Pathways in cancer 💬
1件: AGTR1 💬 Angiotensin II 💬 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224 💬 💬
9 Pathways in cancer 💬
1件: AGTR1 💬 Candesartan 💬 Candesartan 2件: 58, 67 💬 💬
10 Pathways in cancer 💬
1件: AGTR1 💬 Candesartan cilexetil 💬 Candesartan cilexetil 1件: 67 💬 💬
11 Pathways in cancer 💬
1件: AGTR1 💬 Irbesartan 💬 Irbesartan 4件: 66, 167, 168, 222 💬 💬
12 Pathways in cancer 💬
1件: AGTR1 💬 Losartan 💬 Losartan 17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 💬
13 Pathways in cancer 💬
1件: AGTR1 💬 Telmisartan 💬 Telmisartan 2件: 66, 67 💬 💬
14 Pathways in cancer 💬
1件: AGTR1 💬 Valsartan 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬 💬
15 Pathways in cancer 💬
2件: AGTR1, EDNRA 💬 Sparsentan 💬 Sparsentan 3件: 66, 218, 222 💬 💬
16 Pathways in cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬 💬
17 Pathways in cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 1件: 34 💬 💬
18 Pathways in cancer 💬
1件: AR 💬 Calusterone 💬 Calusterone 1件:  2  💬 💬
19 Pathways in cancer 💬
1件: AR 💬 Flutamide 💬 Flutamide 1件: 81 💬 💬
20 Pathways in cancer 💬
1件: AR 💬 Nandrolone 💬 Nandrolone 2件: 60, 85 💬 💬
21 Pathways in cancer 💬
1件: AR 💬 Nandrolone decanoate 💬 Nandrolone decanoate 2件: 60, 85 💬 💬
22 Pathways in cancer 💬
1件: AR 💬 Oxandrolone 💬 Oxandrolone 2件: 211, 285 💬 💬
23 Pathways in cancer 💬
1件: AR 💬 Stanozolol 💬 Stanozolol 1件: 60 💬 💬
24 Pathways in cancer 💬
1件: AR 💬 Testosterone 💬 Testosterone 8件:  1 ,  2 ,  3 , 13, 60, 76, 78, 113 💬 💬
25 Pathways in cancer 💬
1件: AR 💬 Testosterone decanoate 💬 Testosterone decanoate 1件: 113 💬 💬
26 Pathways in cancer 💬
1件: AR 💬 Testosterone enanthate 💬 Testosterone enanthate 1件: 113 💬 💬
27 Pathways in cancer 💬
1件: AR 💬 Testosterone phenylpropionate 💬 Testosterone phenylpropionate 1件: 113 💬 💬
28 Pathways in cancer 💬
1件: AR 💬 Testosterone propionate 💬 Testosterone propionate 1件: 113 💬 💬
29 Pathways in cancer 💬
1件: AR 💬 Testosterone undecanoate 💬 Testosterone undecanoate 2件: 13, 60 💬 💬
30 Pathways in cancer 💬
2件: AR, ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬 💬
31 Pathways in cancer 💬
3件: AR, ESR1, ESR2 💬 Prasterone 💬 Prasterone 6件: 49, 53, 83, 86, 96, 113 💬 💬
32 Pathways in cancer 💬
1件: BCL2 💬 Venetoclax 💬 Venetoclax 1件: 28 💬 💬
33 Pathways in cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬 💬
34 Pathways in cancer 💬
7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬 💬
35 Pathways in cancer 💬
1件: CASP9 💬 Rimiducid 💬 Rimiducid 6件: 19, 60, 65, 284, 285, 326 💬 💬
36 Pathways in cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬 💬
37 Pathways in cancer 💬
7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬 💬
38 Pathways in cancer 💬
3件: CSF1R, FLT3, KIT 💬 Pexidartinib 💬 Pexidartinib 1件: 34 💬 💬
39 Pathways in cancer 💬
1件: CSF2RA 💬 Mavrilimumab 💬 Mavrilimumab 2件: 41, 46 💬 💬
40 Pathways in cancer 💬
1件: CSF2RA 💬 Molgramostim 💬 Molgramostim 3件: 97, 229, 299 💬 💬
41 Pathways in cancer 💬
1件: CSF2RA 💬 Regramostim 💬 Regramostim 1件: 229 💬 💬
42 Pathways in cancer 💬
1件: CSF2RA 💬 Sargramostim 💬 Sargramostim 7件:  6 , 28, 60, 62, 96, 229, 285 💬 💬
43 Pathways in cancer 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 35件:  2 ,  6 , 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 💬
44 Pathways in cancer 💬
1件: CSF3R 💬 Lenograstim 💬 Lenograstim 7件:  2 , 13, 16, 18, 19, 57, 65 💬 💬
45 Pathways in cancer 💬
1件: CSF3R 💬 Pegfilgrastim 💬 Pegfilgrastim 1件: 60 💬 💬
46 Pathways in cancer 💬
1件: CXCR4 💬 Plerixafor 💬 Plerixafor 5件: 19, 20, 65, 285, 299 💬 💬
47 Pathways in cancer 💬
1件: EDNRA 💬 Ambrisentan 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬 💬
48 Pathways in cancer 💬
1件: EDNRA 💬 Sitaxentan 💬 Sitaxentan 1件: 86 💬 💬
49 Pathways in cancer 💬
1件: EDNRA 💬 Zibotentan 💬 Zibotentan 1件: 51 💬 💬
50 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 💬
51 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 💬
52 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 Macitentan 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬 💬
53 Pathways in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 2件: 51, 86 💬 💬
54 Pathways in cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 1件: 94 💬 💬
55 Pathways in cancer 💬
1件: EGFR 💬 Gefitinib 💬 Gefitinib 1件: 75 💬 💬
56 Pathways in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬 💬
57 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬 💬
58 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬 💬
59 Pathways in cancer 💬
3件: EGFR, ERBB2, FLT4 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬 💬
60 Pathways in cancer 💬
1件: EPOR 💬 Peginesatide 💬 Peginesatide 1件: 283 💬 💬
61 Pathways in cancer 💬
1件: ESR1 💬 Desogestrel 💬 Desogestrel 1件: 230 💬 💬
62 Pathways in cancer 💬
1件: ESR1 💬 Ethinyl estradiol 💬 Ethinylestradiol 4件: 13, 46, 49, 299 💬 💬
63 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Clomifene 💬 Clomifene 1件: 74 💬 💬
64 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estetrol 💬 Estetrol 1件: 53 💬 💬
65 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estetrol 💬 Estetrol 1件: 53 💬 💬
66 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estradiol 💬 Estradiol 7件: 13, 46, 49, 65, 76, 226, 299 💬 💬
67 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estradiol valerate 💬 Estradiol valerate 1件: 65 💬 💬
68 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estriol 💬 Estriol 2件: 13, 227 💬 💬
69 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Estriol tripropionate 💬 Estriol 2件: 13, 227 💬 💬
70 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Fulvestrant 💬 Fulvestrant 2件: 49, 86 💬 💬
71 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Mestranol 💬 Mestranol 2件: 46, 49 💬 💬
72 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Raloxifene 💬 Raloxifene 1件: 46 💬 💬
73 Pathways in cancer 💬
2件: ESR1, ESR2 💬 Tamoxifen 💬 Tamoxifen 3件:  2 , 113, 227 💬 💬
74 Pathways in cancer 💬
1件: F2 💬 Dabigatran 💬 Dabigatran 5件: 51, 75, 85, 91, 124 💬 💬
75 Pathways in cancer 💬
1件: F2 💬 Dabigatran etexilate 💬 Dabigatran etexilate 2件: 51, 75 💬 💬
76 Pathways in cancer 💬
1件: F2 💬 Thrombomodulin alfa 💬 Thrombomodulin Alfa 1件: 85 💬 💬
77 Pathways in cancer 💬
1件: FGF23 💬 Burosumab 💬 Burosumab 1件: 238 💬 💬
78 Pathways in cancer 💬
3件: FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬 💬
79 Pathways in cancer 💬
6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬 💬
80 Pathways in cancer 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 5件: 13, 36, 38, 39, 65 💬 💬
81 Pathways in cancer 💬
1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬 💬
82 Pathways in cancer 💬
1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬 💬
83 Pathways in cancer 💬
2件: HDAC1, HDAC2 💬 Vorinostat 💬 Vorinostat 2件: 75, 96 💬 💬
84 Pathways in cancer 💬
1件: HMOX1 💬 Stannsoporfin 💬 Stannsoporfin 1件: 254 💬 💬
85 Pathways in cancer 💬
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 Rontalizumab 💬 Rontalizumab 1件: 49 💬 💬
86 Pathways in cancer 💬
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 Sifalimumab 💬 Sifalimumab 1件: 49 💬 💬
87 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Anifrolumab 💬 Anifrolumab 3件: 46, 49, 53 💬 💬
88 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Interferon alfa 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬 💬
89 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Interferon alfa-2a 💬 Interferon alfa-2a 1件: 56 💬 💬
90 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Interferon alfa-2b 💬 Interferon alfa-2b 2件: 25, 34 💬 💬
91 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Interferon beta-1a 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬 💬
92 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Interferon beta-1b 💬 Interferon beta-1b 1件: 13 💬 💬
93 Pathways in cancer 💬
2件: IFNAR1, IFNAR2 💬 Peginterferon beta-1a 💬 Peginterferon beta-1a 1件: 13 💬 💬
94 Pathways in cancer 💬
1件: IFNG 💬 Emapalumab 💬 Emapalumab 3件: 49, 65, 107 💬 💬
95 Pathways in cancer 💬
1件: IFNG 💬 Fontolizumab 💬 Fontolizumab 1件: 46 💬 💬
96 Pathways in cancer 💬
2件: IFNGR1, IFNGR2 💬 Interferon gamma-1b 💬 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326 💬 💬
97 Pathways in cancer 💬
1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬 💬
98 Pathways in cancer 💬
1件: IGF1R 💬 Mecasermin 💬 Mecasermin 6件: 65, 78, 96, 168, 265, 299 💬 💬
99 Pathways in cancer 💬
1件: IGF1R 💬 Teprotumumab 💬 Teprotumumab 1件: 51 💬 💬
100 Pathways in cancer 💬
3件: IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬 💬
101 Pathways in cancer 💬
1件: IL13 💬 Anrukinzumab 💬 Anrukinzumab 1件: 97 💬 💬
102 Pathways in cancer 💬
1件: IL13 💬 Lebrikizumab 💬 Lebrikizumab 1件: 85 💬 💬
103 Pathways in cancer 💬
1件: IL13 💬 Tralokinumab 💬 Tralokinumab 2件: 85, 97 💬 💬
104 Pathways in cancer 💬
1件: IL23A 💬 Brazikumab 💬 Brazikumab 2件: 96, 97 💬 💬
105 Pathways in cancer 💬
1件: IL23A 💬 Guselkumab 💬 Guselkumab 5件: 37, 41, 51, 96, 97 💬 💬
106 Pathways in cancer 💬
1件: IL23A 💬 Mirikizumab 💬 Mirikizumab 3件: 37, 96, 97 💬 💬
107 Pathways in cancer 💬
1件: IL23A 💬 Risankizumab 💬 Risankizumab 4件: 37, 96, 97, 271 💬 💬
108 Pathways in cancer 💬
1件: IL23A 💬 Tildrakizumab 💬 Tildrakizumab 2件: 162, 271 💬 💬
109 Pathways in cancer 💬
1件: IL2RA 💬 Basiliximab 💬 Basiliximab 6件:  2 , 50, 66, 97, 222, 228 💬 💬
110 Pathways in cancer 💬
1件: IL2RA 💬 Daclizumab 💬 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284 💬 💬
111 Pathways in cancer 💬
3件: IL2RA, IL2RB, IL2RG 💬 Aldesleukin 💬 Aldesleukin 6件:  2 , 35, 49, 65, 96, 97 💬 💬
112 Pathways in cancer 💬
1件: IL4 💬 Binetrakin 💬 Binetrakin 1件: 46 💬 💬
113 Pathways in cancer 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬 💬
114 Pathways in cancer 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬 💬
115 Pathways in cancer 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬 💬
116 Pathways in cancer 💬
1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬 💬
117 Pathways in cancer 💬
1件: IL6 💬 Olokizumab 💬 Olokizumab 2件: 46, 96 💬 💬
118 Pathways in cancer 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 💬
119 Pathways in cancer 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 5件: 28, 51, 85, 227, 331 💬 💬
120 Pathways in cancer 💬
1件: IL6 💬 Siltuximab 💬 Siltuximab 2件: 28, 331 💬 💬
121 Pathways in cancer 💬
1件: IL6 💬 Sirukumab 💬 Sirukumab 2件: 41, 46 💬 💬
122 Pathways in cancer 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬 💬
123 Pathways in cancer 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬 💬
124 Pathways in cancer 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 💬
125 Pathways in cancer 💬
1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬 💬
126 Pathways in cancer 💬
1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬 💬
127 Pathways in cancer 💬
1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬 💬
128 Pathways in cancer 💬
1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬 💬
129 Pathways in cancer 💬
2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬 💬
130 Pathways in cancer 💬
2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬 💬
131 Pathways in cancer 💬
3件: JAK1, JAK2, JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬 💬
132 Pathways in cancer 💬
3件: JAK1, JAK2, JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 💬
133 Pathways in cancer 💬
1件: KEAP1 💬 Dimethyl fumarate 💬 Dimethyl fumarate 5件: 13, 49, 51, 86, 296 💬 💬
134 Pathways in cancer 💬
1件: KIT 💬 Masitinib 💬 Masitinib 6件:  2 ,  5 ,  6 , 13, 46, 96 💬 💬
135 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬 💬
136 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib 1件: 280 💬 💬
137 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 1件: 34 💬 💬
138 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬 💬
139 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 4件:  2 , 34, 279, 280 💬 💬
140 Pathways in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬 💬
141 Pathways in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 💬
142 Pathways in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬 💬
143 Pathways in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 1件: 13 💬 💬
144 Pathways in cancer 💬
1件: NFE2L2 💬 Omaveloxolone 💬 Omaveloxolone 1件: 18 💬 💬
145 Pathways in cancer 💬
1件: NFKB1 💬 Iguratimod 💬 Iguratimod 5件: 46, 51, 53, 271, 300 💬 💬
146 Pathways in cancer 💬
1件: NQO1 💬 Warfarin 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 86, 88, 91 💬 💬
147 Pathways in cancer 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬 💬
148 Pathways in cancer 💬
1件: PIK3CA 💬 Alpelisib 💬 Alpelisib 1件: 138 💬 💬
149 Pathways in cancer 💬
3件: PIK3CA, PIK3CB, PIK3CD 💬 Leniolisib 💬 Leniolisib 2件: 53, 65 💬 💬
150 Pathways in cancer 💬
1件: PIK3CD 💬 Parsaclisib 💬 Parsaclisib 3件: 35, 53, 61 💬 💬
151 Pathways in cancer 💬
3件: PML, RARA, RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬 💬
152 Pathways in cancer 💬
1件: PPARG 💬 Bocidelpar 💬 Bocidelpar 1件: 113 💬 💬
153 Pathways in cancer 💬
1件: PPARG 💬 Leriglitazone 💬 Leriglitazone 1件: 20 💬 💬
154 Pathways in cancer 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 💬
155 Pathways in cancer 💬
1件: PPARG 💬 Rosiglitazone 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬 💬
156 Pathways in cancer 💬
1件: PPARG 💬 Seladelpar 💬 Seladelpar 2件: 93, 94 💬 💬
157 Pathways in cancer 💬
1件: PRKCB 💬 Enzastaurin 💬 Enzastaurin 1件: 168 💬 💬
158 Pathways in cancer 💬
1件: PTGER1 💬 Alprostadil 💬 Alprostadil 2件: 51, 70 💬 💬
159 Pathways in cancer 💬
1件: PTGER1 💬 Limaprost 💬 Limaprost 1件: 70 💬 💬
160 Pathways in cancer 💬
3件: PTGER2, PTGER3, PTGER4 💬 Misoprostol 💬 Misoprostol 3件: 46, 70, 271 💬 💬
161 Pathways in cancer 💬
1件: PTGS2 💬 Aceclofenac 💬 Aceclofenac 1件: 46 💬 💬
162 Pathways in cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 15件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬 💬
163 Pathways in cancer 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 14件: 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 💬 💬
164 Pathways in cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬 💬
165 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬 💬
166 Pathways in cancer 💬
1件: PTGS2 💬 Diflunisal 💬 Diflunisal 1件: 28 💬 💬
167 Pathways in cancer 💬
1件: PTGS2 💬 Etodolac 💬 Etodolac 1件: 46 💬 💬
168 Pathways in cancer 💬
1件: PTGS2 💬 Etoricoxib 💬 Etoricoxib 2件: 46, 271 💬 💬
169 Pathways in cancer 💬
1件: PTGS2 💬 Flurbiprofen 💬 Flurbiprofen 3件: 13, 21, 46 💬 💬
170 Pathways in cancer 💬
1件: PTGS2 💬 Ibuprofen 💬 Ibuprofen 7件: 13, 46, 65, 107, 113, 271, 299 💬 💬
171 Pathways in cancer 💬
1件: PTGS2 💬 Indomethacin 💬 Indomethacin 3件: 225, 271, 298 💬 💬
172 Pathways in cancer 💬
1件: PTGS2 💬 Ketoprofen 💬 Ketoprofen 1件: 46 💬 💬
173 Pathways in cancer 💬
1件: PTGS2 💬 Ketorolac 💬 Ketorolac 2件: 70, 226 💬 💬
174 Pathways in cancer 💬
1件: PTGS2 💬 Loxoprofen 💬 Loxoprofen 2件: 46, 271 💬 💬
175 Pathways in cancer 💬
1件: PTGS2 💬 Lumiracoxib 💬 Lumiracoxib 1件: 46 💬 💬
176 Pathways in cancer 💬
1件: PTGS2 💬 Meloxicam 💬 Meloxicam 4件: 46, 49, 271, 296 💬 💬
177 Pathways in cancer 💬
1件: PTGS2 💬 Naproxen 💬 Naproxen 4件: 13, 46, 107, 271 💬 💬
178 Pathways in cancer 💬
1件: PTGS2 💬 Nimesulide 💬 Nimesulide 1件: 46 💬 💬
179 Pathways in cancer 💬
1件: PTGS2 💬 Parecoxib 💬 Parecoxib 2件: 46, 271 💬 💬
180 Pathways in cancer 💬
1件: PTGS2 💬 Rofecoxib 💬 Rofecoxib 1件: 46 💬 💬
181 Pathways in cancer 💬
1件: PTGS2 💬 Salsalate 💬 Salsalate 1件:  5  💬 💬
182 Pathways in cancer 💬
1件: PTGS2 💬 Sulindac 💬 Sulindac 1件: 206 💬 💬
183 Pathways in cancer 💬
1件: PTGS2 💬 Tolfenamic acid 💬 Tolfenamic acid 1件:  5  💬 💬
184 Pathways in cancer 💬
1件: PTGS2 💬 Valdecoxib 💬 Valdecoxib 1件: 46 💬 💬
185 Pathways in cancer 💬
1件: RARA 💬 Tamibarotene 💬 Tamibarotene 2件: 26, 96 💬 💬
186 Pathways in cancer 💬
2件: RARA, RARB 💬 Fenretinide 💬 Fenretinide 1件: 299 💬 💬
187 Pathways in cancer 💬
2件: RARA, RARB 💬 Isotretinoin 💬 Isotretinoin 4件: 36, 39, 159, 160 💬 💬
188 Pathways in cancer 💬
2件: RARA, RARB 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬 💬
189 Pathways in cancer 💬
5件: RARA, RARB, RXRA, RXRB, RXRG 💬 Acitretin 💬 Acitretin 1件: 37 💬 💬
190 Pathways in cancer 💬
5件: RARA, RARB, RXRA, RXRB, RXRG 💬 Alitretinoin 💬 Alitretinoin 1件: 49 💬 💬
191 Pathways in cancer 💬
1件: RELA 💬 Edasalonexent 💬 Edasalonexent 1件: 113 💬 💬
192 Pathways in cancer 💬
2件: ROCK1, ROCK2 💬 Fasudil 💬 Fasudil 4件:  2 ,  5 ,  7 , 51 💬 💬
193 Pathways in cancer 💬
1件: ROCK2 💬 Belumosudil 💬 Belumosudil 2件: 51, 85 💬 💬
194 Pathways in cancer 💬
3件: RXRA, RXRB, RXRG 💬 Bexarotene 💬 Bexarotene 2件: 13, 75 💬 💬
195 Pathways in cancer 💬
1件: SMO 💬 Taladegib 💬 Taladegib 1件: 85 💬 💬
196 Pathways in cancer 💬
1件: SMO 💬 Vismodegib 💬 Vismodegib 1件: 85 💬 💬
197 Pathways in cancer 💬
3件: TGFB1, TGFB2, TGFB3 💬 Fresolimumab 💬 Fresolimumab 3件: 51, 85, 222 💬 💬
198 Pathways in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬 💬
199 Pathways in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬 💬